Oncology Nursing News
6 FOLLOWERS
Oncology Nursing News is a blog founded in 2012 that focuses on providing nursing professionals with the latest news, research, and updates in the field of oncology nursing. Their mission is to help oncology nurses stay informed and up-to-date on the latest developments in cancer care, treatment, and research.
Oncology Nursing News
13h ago
A phase 2 trial found that pembrolizumab plus pemetrexed met its objective response rate primary end point ..read more
Oncology Nursing News
1d ago
Working with interdisciplinary teams and nurse navigators to coordinate care across specialties is a facet of oncology nursing that may be overlooked, says an expert ..read more
Oncology Nursing News
2d ago
Palbociclib plus letrozole lengthened PFS vs placebo plus letrozole for patients with ER-positive advanced or recurrent endometrial cancer ..read more
Oncology Nursing News
2d ago
Experts discuss how to balance treatment intensity with maintaining quality of life, particularly in patients with advanced-stage disease ..read more
Oncology Nursing News
2d ago
Experts discuss effective communication strategies for managing patient and caregiver expectations about treatment adverse effects and their potential impact on daily life ..read more
Oncology Nursing News
2d ago
Patricia Jakel, MN, RN, AOCN, emphasized that the bond oncology nurses have with patients with cancer necessitates honest and often difficult conversations ..read more
Oncology Nursing News
3d ago
Two denosumab biosimilars have been approved by the FDA for all previously approved uses for the reference drugs in cancers and osteoporosis ..read more
Oncology Nursing News
3d ago
A recent study found that toxicity is routinely minimized in phase 3 oncology trials, especially those that are not industry sponsored ..read more
Oncology Nursing News
3d ago
Adding antihistamines to atezolizumab led to a 46% OS rate and a 23% PFS rate in metastatic urothelial carcinoma ..read more
Oncology Nursing News
4d ago
Key opinion leaders compare lorlatinib’s side effect profile to other ALK inhibitors, highlighting unique challenges and benefits observed in clinical practice ..read more